
    
      This study was designed to evaluate the safety of a continuous infusion of dexmedetomidine (1
      mcg/kg loading dose with 0.6 mcg/kg/hr initial maintenance dose and titrated between 0.2-1.0
      mcg/kg/hr) administered to subjects requiring non-intubated, spontaneous breathing, moderate
      to deep sedation (NI-MDS) for elective diagnostic or therapeutic procedures that are expected
      to take more than 30 minutes.
    
  